Evidence map›Paper›PMID 39193795›Full record

ArticleEpigenomics2024

Epigenetic identification of LTBP4 as a putative tumor suppressor in breast cancer.

Wenfeng He, Jingheng Zhang, Siyuan Wen, Ying Li, Lin Shen, Tiejun Zhou, Qinglian Wen, Yu Fan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epigenomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wenfeng HeDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, 646000, Luzhou, PR China.
Jingheng ZhangDepartment of Oncology, The People's Hospital of Luzhou, 646000, Luzhou, PR China.
Siyuan WenFaculty of Clinical Medicine, Southwest Medical University, 646000, Luzhou, PR China.
Ying LiFaculty of Clinical Medicine, Southwest Medical University, 646000, Luzhou, PR China.
Lin ShenFaculty of Clinical Medicine, Southwest Medical University, 646000, Luzhou, PR China.
Tiejun ZhouDepartment of Pathology, The Affiliated Hospital of Southwest Medical University, 646000, Luzhou, PR China.
Qinglian WenDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, 646000, Luzhou, PR China.
Yu FanDepartment of Oncology, The Affiliated Hospital of Southwest Medical University, 646000, Luzhou, PR China.

Funding

Beijing Kechuang Medical Development Foundation KC2023-JX-0288-BM74Natural Science Foundation of Sichuan Province 2022NSFSC1425
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsDNA MethylationEpigenesis, GeneticGene Expression Regulation, NeoplasticPromoter Regions, GeneticBiomarkers, TumorFemaleGenes, Tumor SuppressorHumansLatent TGF-beta Binding ProteinsPrognosisBiomarkers, TumorLatent TGF-beta Binding Proteinsbreast cancercell adhesion moleculeDNA methylationimmune microenvironmentLTBP4tumor suppressor

Identifiers

PMID39193795
PMCPMC11404579

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.